Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TH-Overfladebehandling ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.8%   Bankruptcy risk   3.1% 5.1% 1.9% 1.1% 14.7% 6.5% 20.6% 17.2%   Credit score (0-100)   58 45 71 82 13 35 5 10   Credit rating   BBB BBB A A BB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.6 78.2 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,438 2,122 3,236 3,293 4,782 3,267 0.0 0.0   EBITDA   603 286 1,023 1,108 1,434 365 0.0 0.0   EBIT   375 58.0 645 795 -1,701 323 0.0 0.0   Pre-tax profit (PTP)   299.0 18.0 639.0 795.0 -1,708.0 276.3 0.0 0.0   Net earnings   232.0 14.0 498.0 620.0 -1,953.0 215.7 0.0 0.0   Pre-tax profit without non-rec. items   299 18.0 639 795 -1,708 276 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,004 1,116 759 467 175 201 0.0 0.0   Shareholders equity total   357 371 869 1,489 -464 -248 -373 -373   Interest-bearing liabilities   1,178 995 109 339 1,878 922 373 373   Balance sheet total (assets)   2,070 1,730 1,936 2,707 2,976 1,270 0.0 0.0   Net Debt   1,053 785 109 339 1,878 397 373 373     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,438 2,122 3,236 3,293 4,782 3,267 0.0 0.0   Gross profit growth   0.0% -13.0% 52.5% 1.8% 45.2% -31.7% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,070 1,730 1,936 2,707 2,976 1,270 0 0   Balance sheet change%   0.0% -16.4% 11.9% 39.8% 9.9% -57.3% -100.0% 0.0%   Added value   603.0 286.0 1,023.0 1,108.0 -1,388.0 364.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   856 -136 -755 -625 -3,447 -15 -201 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.4% 2.7% 19.9% 24.1% -35.6% 9.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.5% 3.6% 35.6% 34.5% -54.5% 13.2% 0.0% 0.0%   ROI %   24.4% 4.5% 53.9% 55.8% -89.2% 23.4% 0.0% 0.0%   ROE %   65.0% 3.8% 80.3% 52.6% -87.5% 10.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.2% 21.4% 44.9% 55.0% -14.1% -16.3% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   174.6% 274.5% 10.7% 30.6% 131.0% 108.9% 0.0% 0.0%   Gearing %   330.0% 268.2% 12.5% 22.8% -404.7% -372.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.1% 4.6% 2.4% 2.7% 2.9% 3.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.9 1.6 0.7 0.5 0.0 0.0   Current Ratio   0.6 0.4 1.1 1.9 0.8 0.7 0.0 0.0   Cash and cash equivalent   125.0 210.0 0.0 0.0 0.0 525.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -697.0 -743.0 84.0 1,053.0 -588.0 -394.2 -186.3 -186.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   603 286 1,023 1,108 -1,388 365 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   603 286 1,023 1,108 1,434 365 0 0   EBIT / employee   375 58 645 795 -1,701 323 0 0   Net earnings / employee   232 14 498 620 -1,953 216 0 0